Cellectis (CLLS) Said to IPO Calyxt Unit
Tweet
Share
E-mailGet Alerts CLLS Hot Sheet
Join SI Premium – FREE
Cellectis (NASDAQ: CLLS) gained pre-market Thursday on talk it plans to IPO its Calyxt unit. Comments about the IPO were made by management at a biotech seminar, according to reports.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karman Line Acquisition prices $200M IPO on Nasdaq
- Wolfpack Research: 'we are short FTK because their $400m deal has been canceled'
- Buss family to sell rest of Lakers stake to Kushner, Iger - ESPN
Create E-mail Alert Related Categories
IPOs, Management Comments, Spinoffs, Trader TalkRelated Entities
IPOSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
